NOVO HOLDINGS A/S
Filing Date
Global Rank
#1,776
/ 8,794
▲ 91
· as of Jun 2026
Top Industry
Biotechnology
72.4%
Period ended 3 months ago
Filed Aug 14, 2026 · 52d
26 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
25 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
12.7%
−1.0 pts
Top 5
49.0%
−2.3 pts
Top 10
73.7%
−0.2 pts
HHI
700
Diversified−35
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 72.4% | $1,241,938,796 |
| Technology | 14.7% | $252,278,760 |
| Financial Services | 8.7% | $148,905,074 |
| Consumer Cyclical | 4.2% | $72,008,165 |
| Industrials | 0.1% | $1,078,569 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVBP | ArriVent BioPharma, Inc. | −442,142 | 1,500,000 | $52,110,000 | |
| FDMT | 4D Molecular Therapeutics, Inc. | −401,559 | 3,249,178 | $43,214,067 | |
| PHVS | Pharvaris N.V. | −350,000 | 1,400,000 | $48,412,000 | |
| ELVN | Enliven Therapeutics, Inc. | −280,000 | 1,000,000 | $50,750,000 | |
| — | −230,000 | 1,320,000 | $49,394,400 | ||
| MIRM | Mirum Pharmaceuticals, Inc. | −200,000 | 1,125,000 | $131,703,750 | |
| CLDX | Celldex Therapeutics, Inc. | −175,000 | 1,025,000 | $38,140,250 | |
| PCVX | Vaxcyte, Inc. | −60,000 | 800,000 | $46,504,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, Inc. | 4,180,550 | $153,551,601 | |
| AVLN | Avalyn Pharma Inc. | 3,883,289 | $127,837,873 | |
| FND | Floor & Decor Holdings, Inc. | 797,000 | $47,309,920 | |
| ALMS | Alumis Inc. | 1,100,000 | $30,954,000 | |
| DYN | Dyne Therapeutics, Inc. | 960,394 | $21,330,350 | |
| INSM | INSMED Inc | 120,723 | $12,871,486 | |
| No positions match the current search. | ||||
25 tracked positions ·
$1,716,209,364 total
· filing declares
25 positions · $1,722,216,880
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 5,350,000 | $217,370,500 | 12.67% | |
| ASML |
Asml Holding NV
Technology
|
Held | 94,946 | $188,889,360 | 11.01% | |
| COAG |
Hemab Therapeutics Holdings, Inc.
Healthcare
|
NEW | 4,180,550 | $153,551,601 | 8.95% | |
| BN |
BROOKFIELD Corp /ON/
Financial Services
|
Held | 3,496,245 | $148,905,074 | 8.68% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Held | 3,686,622 | $132,128,532 | 7.70% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,125,000 | $131,703,750 | 7.67% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 3,883,289 | $127,837,873 | 7.45% | |
| CRM |
Salesforce, Inc.
Technology
|
Held | 393,187 | $61,596,675 | 3.59% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Reduced | 1,500,000 | $52,110,000 | 3.04% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 1,000,000 | $50,750,000 | 2.96% | |
|
|
Reduced | 1,320,000 | $49,394,400 | 2.88% | ||
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 1,400,000 | $48,412,000 | 2.82% | |
| FND |
Floor & Decor Holdings, Inc.
Consumer Cyclical
|
NEW | 797,000 | $47,309,920 | 2.76% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 800,000 | $46,504,000 | 2.71% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Reduced | 3,249,178 | $43,214,067 | 2.52% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 2,135,000 | $39,219,950 | 2.29% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,025,000 | $38,140,250 | 2.22% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 1,100,000 | $30,954,000 | 1.80% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 485,438 | $29,301,037 | 1.71% | |
| BABA |
Alibaba Group Holding Ltd
Consumer Cyclical
|
Held | 257,327 | $24,698,245 | 1.44% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
NEW | 960,394 | $21,330,350 | 1.24% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Added | 2,250,000 | $17,145,000 | 1.00% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 120,723 | $12,871,486 | 0.75% | |
| MQ |
Marqeta, Inc.
Technology
|
Held | 441,558 | $1,792,725 | 0.10% | |
| LNZA |
LanzaTech Global, Inc.
Industrials
|
Held | 158,148 | $1,078,569 | 0.06% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.